1-3 of 3
Elisabetta Lisi
Close
Sort by
Journal Articles

Novel Agents Versus Conventional Drugs for the Treatment of Relapsed Multiple Myeloma Patients: Experience of a Single Center over the Last 25 Years

Sara Grammatico, Elisabetta Lisi, PhD, Laura Cesini, MD, Maria Letizia Vallone, PhD, Saveria Capria, MD, Robin FoÃ, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2015) 126 (23): 5385.
https://doi.org/10.1182/blood.V126.23.5385.5385
Published: 2015
Journal Articles

Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions

Ombretta Annibali, MDPhD, Maria Teresa Petrucci, MD, Daniele Santini, MD, Elisabetta Lisi, PhD, MArco Mariani, Francesco Pisani, Member, ID:, 1012314, Velia Bongarzoni, Olga Venditti, MD, Angela Rago, Elisabetta Cerchiara, MD, Alessia Fiorini, MD, Luca Franceschini, MD, Stefano Felici, MD, MArco Russano, MD, Francesco PAntano, MD, Giuseppe Avvisati, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5359.
https://doi.org/10.1182/blood.V126.23.5359.5359
Published: 2015
Journal Articles

Clinical Features and Prognostic Factors in Solitary Plasmacytoma: A Single Center Retrospective Study

Paola Finsinger, MD, Fabiana Gentilini, MDPhD, Marta Chisini, Francesca Prestanicola, Letizia Maria Vallone, Elisabetta Lisi, Robin Foa, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2014) 124 (21): 3455.
https://doi.org/10.1182/blood.V124.21.3455.3455
Published: 2014